Baby's hand holding its mother's finger


Latest News


Sera Prognostics Announces Pricing of Initial Public Offering

July 14, 2021 – Sera today announced the pricing of its initial public offering of 4,687,500 shares of its common stock at a price to the public of $16.00 per share.

Sera Prognostics and Anthem, Inc. Announce Commercial Partnership Leveraging Innovative Biomarker Test to Reduce Risk of Preterm Birth

May 19, 2021-The PreTRM® Test Is Designed to Build a Foundation for Healthy Communities One Baby at a Time

Evaluation Of Health And Economic Benefit Of The PreTRM® Test-and-treat Strategy To Improve Maternal And Infant Health Among Commercially Insured In The Us

May 18, 2021-Data presented at the ISPOR 2021 Conference illustrating clinical benefit as well as cost savings

Sera Prognostics Completes $100 Million Series E Financing

April 28, 2021-Several prominent healthcare-focused institutional investors fund Sera to expand commercialization of the PreTRM® Test.

Sera Prognostics Appoints Benjamin G. Jackson as General Counsel

April 13, 2021-Highly accomplished attorney joins Sera to develop its legal and intellectual property functions.

Sera Prognostics Appoints Robert G. Harrison As Chief Information Officer

March 31, 2021- Accomplished technology leader joins Sera to build and deploy its information strategy.

American Medical Association (AMA) Grants Sera Prognostics A Cpt® Pla Code For PreTRM®, The Only Broadly Validated Blood Test To Assess Risk Of Preterm Birth

February 3, 2021- Receipt of dedicated CPT® code marks important commercialization milestone to pursue reimbursement for the PreTRM® Test.

Sera Prognostics Partners With Anthem and HealthCore to Improve Outcomes for Preterm Babies

January 05, 2021- Patient enrollment began in November for this rigorous prospective, randomized, controlled PRIME intervention trial to demonstrate the value of implementing the PreTRM® prevention strategy to improve neonatal outcomes and lower cost of care.

Sera Prognostics to Present at Baird’s 2020 Global Health Care Conference

September 9, 2020- Sera will be presenting at the upcoming Baird 2020 Global Health Care Conference. A virtual conference, Sera’s presentation will take place on Thursday, September 10 at 10:50 a.m. ET.

Sera Prognostics Appoints Thomas J. Garite, M.D. as Vice President of Clinical Sciences

June 24, 2020 – Sera announced the appointment Thomas J. Garite, M.D. as Vice President of Clinical Sciences. – Dr. Garite will support clinical development and operations as Sera transitions from clinical to commercial-stage company.

Stay in Touch